Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey)
NCT02925663 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2020-02-05
Summary
The purpose of this study is to establish the feasibility, accessibility, acceptability, and preliminary efficacy of an individually-tailored intervention to improve EF in adolescents with epilepsy (EFI-E).
Conditions
Interventions
- BEHAVIORAL
-
EFI-E
This is 10 web-based modules addressing foundational EF skills. Each online module will be accompanied by a videoconference with a therapist to review the skills and problem solve around adolescent-identified goals.
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-10
- Primary Completion
- 2018-01-04
- Completion
- 2018-06-28
More Related Trials
-
Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy
NCT00550940 ·Status: COMPLETED
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
Sleep Intervention for Pediatric Epilepsy
NCT02514291 ·Status: COMPLETED ·Phase: NA
-
Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy
NCT06661759 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Efficacy of a Mobile Epilepsy Education Application
NCT06402526 ·Status: COMPLETED ·Phase: NA
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Goals for Epilepsy Clinic Visits Trial
NCT05928598 ·Status: RECRUITING ·Phase: NA
-
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
NCT06623994 ·Status: RECRUITING ·Phase: NA
-
Effects of Eslicarbazepine Acetate (Esl, Bia 2-093) on Cognitive Function in Children With Partial Onset Seizures
NCT01527513 ·Status: COMPLETED ·Phase: PHASE2
-
Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis
NCT06701084 ·Status: RECRUITING ·Phase: NA
-
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
NCT00235755 ·Status: COMPLETED ·Phase: PHASE3
-
Creation, Implementation, and Analysis of a Seizure Action Plan
NCT02995759 ·Status: COMPLETED
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
Effects of Mega-dose Vitamin D Pulse and Maintenance Therapy on Seizure Frequency, Fatigue, and Quality of Life: A Prospective Study
NCT06736002 ·Status: RECRUITING ·Phase: NA
-
Self-management for People with Epilepsy
NCT04705441 ·Status: COMPLETED ·Phase: NA
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Web-Based Epilepsy Education Program for Adolescents and Parents
NCT04144478 ·Status: COMPLETED ·Phase: NA
-
Seizures and Traumatic Brain Injury Rehabilitation
NCT05823168 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
NCT00236756 ·Status: COMPLETED ·Phase: PHASE3